SOPH: Multiple Rule 10b5-1 Insider Sales Reported

SOPH reports multiple Rule 10b5-1 sales by Jurgi Camblong.

Rhea-AI Filing Summary

SOPH reports multiple Rule 10b5-1 sales by Jurgi Camblong. The filing lists numerous planned sales of Common stock executed under a 10b5-1 plan between 12/19/2025 and 03/13/2026, including 95,488 shares on 01/09/2026 (amount 491,626.46) and 37,299 shares on 01/22/2026 (amount 209,917.83).

Insights

Securities Compliance Analyst

Notice lists routine 10b5-1 sales by a reporting person.

The filing catalogs multiple scheduled sales by Jurgi Camblong executed under a 10b5-1 plan across late 2025 and early 2026. The entries show share counts and corresponding proceeds figures for each trade date, indicating systematic dispositions.

Cash‑flow treatment and any remaining holdings are not stated in the excerpt; subsequent filings may provide post‑transaction positions.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does the SOPH Form 144 disclose about insider sales?

The filing discloses multiple 10b5-1 sales by Jurgi Camblong between 12/19/2025 and 03/13/2026, listing per‑trade share counts and proceeds such as 95,488 shares for 491,626.46 on 01/09/2026.

Who executed the sales reported in the SOPH filing?

The reported sales were executed under a 10b5-1 plan by Jurgi Camblong. The entry lines identify the same reporting person and show multiple trade dates with share quantities and corresponding proceeds figures.

Which trade dates and sample quantities appear in the SOPH excerpt?

Sample dates and quantities include 01/09/2026 (95,488 shares; amount 491,626.46) and 01/22/2026 (37,299 shares; amount 209,917.83). The excerpt lists many additional sale dates and amounts.

Does the filing state how the proceeds are treated for SOPH?

The excerpt lists per‑trade amounts but does not state who receives proceeds or how proceeds will be used. The filing shows proceeds figures per sale without specifying recipient treatment in the provided text.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 03/16/2026 - 04:40 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0002007050
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	SOPHIA GENETICS SA
SEC File Number	001-40627
Address of Issuer	La Piece 12 ch-1180 Rolle SWITZERLAND 00000
Phone	41216941060
Name of Person for Whose Account the Securities are To Be Sold	JURGI CAMBLONG
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Director
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	1984	9146.24	68486338	03/16/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	03/18/2021	Founders Shares	Issuer			1984	03/18/2021	N/A

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
10b5-1 Sales for JURGI CAMBLONG La Piece 12 ch-1180 Rolle V8 00000	Common	03/13/2026	376	1767.95
10b5-1 Sales for JURGI CAMBLONG La Piece 12 ch-1180 Rolle V8 00000	Common	02/19/2026	4486	21612.20
10b5-1 Sales for JURGI CAMBLONG La Piece 12 ch-1180 Rolle V8 00000	Common	02/10/2026	8500	41499.55
10b5-1 Sales for JURGI CAMBLONG La Piece 12 ch-1180 Rolle V8 00000	Common	01/23/2026	200	1120.00
10b5-1 Sales for JURGI CAMBLONG La Piece 12 ch-1180 Rolle V8 00000	Common	01/22/2026	37299	209917.83
10b5-1 Sales for JURGI CAMBLONG La Piece 12 ch-1180 Rolle V8 00000	Common	01/20/2026	24450	134230.50
10b5-1 Sales for JURGI CAMBLONG La Piece 12 ch-1180 Rolle V8 00000	Common	01/16/2026	31909	173943.17
10b5-1 Sales for JURGI CAMBLONG La Piece 12 ch-1180 Rolle V8 00000	Common	01/13/2026	1569	8237.25
10b5-1 Sales for JURGI CAMBLONG La Piece 12 ch-1180 Rolle V8 00000	Common	01/12/2026	2569	13789.52
10b5-1 Sales for JURGI CAMBLONG La Piece 12 ch-1180 Rolle V8 00000	Common	01/09/2026	95488	491626.46
10b5-1 Sales for JURGI CAMBLONG La Piece 12 ch-1180 Rolle V8 00000	Common	01/08/2026	17933	88061.79
10b5-1 Sales for JURGI CAMBLONG La Piece 12 ch-1180 Rolle V8 00000	Common	01/07/2026	35353	174035.75
10b5-1 Sales for JURGI CAMBLONG La Piece 12 ch-1180 Rolle V8 00000	Common	01/06/2026	16948	81669.02
10b5-1 Sales for JURGI CAMBLONG La Piece 12 ch-1180 Rolle V8 00000	Common	01/05/2026	2025	9335.86
10b5-1 Sales for JURGI CAMBLONG La Piece 12 ch-1180 Rolle V8 00000	Common	01/02/2026	4627	21586.34
10b5-1 Sales for JURGI CAMBLONG La Piece 12 ch-1180 Rolle V8 00000	Common	12/31/2025	13696	64195.14
10b5-1 Sales for JURGI CAMBLONG La Piece 12 ch-1180 Rolle V8 00000	Common	12/30/2025	14466	68956.04
10b5-1 Sales for JURGI CAMBLONG La Piece 12 ch-1180 Rolle V8 00000	Common	12/29/2025	2320	10823.26
10b5-1 Sales for JURGI CAMBLONG La Piece 12 ch-1180 Rolle V8 00000	Common	12/22/2025	2000	9488.80
10b5-1 Sales for JURGI CAMBLONG La Piece 12 ch-1180 Rolle V8 00000	Common	12/19/2025	2487	11502.13

144: Remarks and Signature

Remarks
Date of Notice	03/16/2026
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	08/28/2025
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Jurgi Camblong
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)